Related references
Note: Only part of the references are listed.Inflammation and elevated levels of fibroblast growth factor 23 are independent risk factors for death in chronic kidney disease
Jair Munoz Mendoza et al.
KIDNEY INTERNATIONAL (2017)
Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production
Valentin David et al.
KIDNEY INTERNATIONAL (2016)
Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease
Saurav Singh et al.
KIDNEY INTERNATIONAL (2016)
High Fibroblast Growth Factor 23 Levels Associated With Low Hemoglobin Levels in Patients With Chronic Kidney Disease Stages 3 and 4
Ming-Hsien Tsai et al.
MEDICINE (2016)
Activation of Cardiac Fibroblast Growth Factor Receptor 4 Causes Left Ventricular Hypertrophy
Alexander Grabner et al.
CELL METABOLISM (2015)
Renal erythropoietin-producing cells in health and disease
Tomokazu Souma et al.
FRONTIERS IN PHYSIOLOGY (2015)
FGF-23 Is a Negative Regulator of Prenatal and Postnatal Erythropoiesis*
Lindsay M. Coe et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Fibroblast Growth Factor-23 and Cardiovascular Events in CKD
Julia J. Scialla et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women
Myles Wolf et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2013)
Chronic kidney disease: global dimension and perspectives
Vivekanand Jha et al.
LANCET (2013)
Targeting the hepcidin-ferroportin axis to develop new treatment strategies for anemia of chronic disease and anemia of inflammation
Chia Chi Sun et al.
AMERICAN JOURNAL OF HEMATOLOGY (2012)
Treatment of erythropoietin deficiency in mice with systemically administered siRNA
William Querbes et al.
BLOOD (2012)
FGF23 acts directly on renal proximal tubules to induce phosphaturia through activation of the ERK1/2-SGK1 signaling pathway
Olena Andrukhova et al.
BONE (2012)
FGF23 neutralization improves chronic kidney disease-associated hyperparathyroidism yet increases mortality
Victoria Shalhoub et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Hypoxia-inducible factor regulates hepcidin via erythropoietin-induced erythropoiesis
Qingdu Liu et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
REGULATION AND FUNCTION OF THE FGF23/KLOTHO ENDOCRINE PATHWAYS
Aline Martin et al.
PHYSIOLOGICAL REVIEWS (2012)
FGF23 is correlated with iron status but not with inflammation and decreases after iron supplementation: a supplementation study
Vickie Braithwaite et al.
INTERNATIONAL JOURNAL OF PEDIATRIC ENDOCRINOLOGY (2012)
Oxygen-regulated expression of the erythropoietin gene in the human renal cell line REPC
Stilla Frede et al.
BLOOD (2011)
Iron Modifies Plasma FGF23 Differently in Autosomal Dominant Hypophosphatemic Rickets and Healthy Humans
Erik A. Imel et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
FGF23 induces left ventricular hypertrophy
Christian Faul et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease
Tamara Isakova et al.
KIDNEY INTERNATIONAL (2011)
Isolation and Characterization of Renal Erythropoietin-Producing Cells from Genetically Produced Anemia Mice
Xiaoqing Pan et al.
PLOS ONE (2011)
Iron deficiency drives an autosomal dominant hypophosphatemic rickets (ADHR) phenotype in fibroblast growth factor-23 (Fgf23) knock-in mice
Emily G. Farrow et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Plasma interleukin-6 is independently associated with mortality in both hemodialysis and pre-dialysis patients with chronic kidney disease
Daniela V. Barreto et al.
KIDNEY INTERNATIONAL (2010)
Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease
Hisashi Hasegawa et al.
KIDNEY INTERNATIONAL (2010)
Depressed expression of Klotho and FGF receptor 1 in hyperplastic parathyroid glands from uremic patients
Hirotaka Komaba et al.
KIDNEY INTERNATIONAL (2010)
Angiotensin II overcomes strain-dependent resistance of rapid CKD progression in a new remnant kidney mouse model
Asada Leelahavanichkul et al.
KIDNEY INTERNATIONAL (2010)
Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation
Regina Goetz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Iron Indices in Chronic Kidney Disease in the National Health and Nutritional Examination Survey 1988-2004
Steven Fishbane et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis
Orlando M. Gutierrez et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Fibroblast growth factor 23 impairs phosphorus and vitamin D metabolism in vivo and suppresses 25-hydroxyvitamin D-1α-hydroxylase expression in vitro
Farzana Perwad et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2007)
Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: The mild to moderate kidney disease (MMKD) study
Danilo Fliser et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis
Shoji Ichikawa et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Chronic kidney disease as a global public health problem: Approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes
A. S. Levey et al.
KIDNEY INTERNATIONAL (2007)
Correlation between hyperphosphatemia and type IINa-Pi cotransporter activity in klotho mice
Hiroko Segawa et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2007)
Molecular control of iron transport
Tomas Ganz
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Klotho converts canonical FGF receptor into a specific receptor for FGF23
Itaru Urakawa et al.
NATURE (2006)
Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure - The anemia in chronic heart failure: Outcomes and Resource Utilization (ANCHOR) Study
Alan S. Go et al.
CIRCULATION (2006)
Regulation of fibroblast growth factor-23 signaling by Klotho
H Kurosu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease
O Gutierrez et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Abnormal erythroid differentiation in neonatal bcl-6-deficient mice
S Asari et al.
EXPERIMENTAL HEMATOLOGY (2005)
FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis
T Shimada et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2004)
Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism
T Shimada et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
AS Go et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization
E Nemeth et al.
SCIENCE (2004)
Association between serum ferritin and measures of inflammation, nutrition and iron in haemodialysis patients
K Kalantar-Zadeh et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2004)
Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice
D Sitara et al.
MATRIX BIOLOGY (2004)
IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin
E Nemeth et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation
T Ganz
BLOOD (2003)
Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia.
KB Jonsson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23
KE White et al.
KIDNEY INTERNATIONAL (2001)
Lack of angiotensin II-facilitated erythropoiesis causes anemia in angiotensin-converting enzyme-deficient mice
J Cole et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23
KE White et al.
NATURE GENETICS (2000)
Share Paper
